Login / Signup

Is there any association between acute kidney injury and olaparib use in patients with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial.

Kadri Altundag
Published in: Breast cancer (Tokyo, Japan) (2023)
Keyphrases
  • early breast cancer
  • acute kidney injury
  • breast cancer risk
  • cardiac surgery
  • study protocol
  • clinical trial
  • phase iii
  • phase ii
  • randomized controlled trial
  • open label